Ardelyx, Inc. (ARDX)
5.595
+0.06
(+0.99%)
USD |
NASDAQ |
Jun 09, 16:00
5.595
0.00 (0.00%)
After-Hours: 16:43
Ardelyx EPS Diluted (Quarterly) : -0.153 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | -0.4835 |
| Relay Therapeutics, Inc. | -0.4075 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.60M |
| Revenue (Quarterly) | 94.47M |
| Total Expenses (Quarterly) | 132.08M |
| Enterprise Value | 1.338B |
| Gross Profit Margin (Quarterly) | 93.94% |
| Profit Margin (Quarterly) | -39.80% |
| Earnings Yield | -4.26% |
| Normalized Earnings Yield | -4.257 |